Company news
Design Therapeutics, Inc. (NASDAQ:DSGN) news
Design Therapeutics, Inc. news releases on 6ix. Latest, Feb 10, 2022: Design Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
Press releases — page 2
Design Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 9, 2022
Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
January 31, 2022
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
November 8, 2021
vTv Therapeutics Announces Deepa Prasad as New President and CEO
October 19, 2021
Design Therapeutics Announces Positive Preclinical Data Highlighting Disease-Modifying Potential of its Novel DM1 GeneTACs as a Treatment for Myotonic Dystrophy Type-1
September 7, 2021
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
August 8, 2021
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
June 6, 2021
Design Therapeutics Expands Board of Directors with Key Appointments
June 6, 2021
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
May 9, 2021
Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 29, 2021
Design Therapeutics Announces Pricing of Initial Public Offering
March 24, 2021